Table 1.
Baseline characteristic | Efficacy-evaluable population (N = 479) | Intent-to-treat population (N = 494) |
---|---|---|
Age category, n (%) | ||
Pediatric (2 to <15 years) | 187 (39%) | 190 (38%) |
2 to <5 years | 19 (4%) | 19 (4%) |
5 to <15 years | 168 (35%) | 171 (35%) |
Adult (≥15 to 55 years) | 292 (61%) | 304 (62%) |
Sex, n (%) | ||
Male | 295 (62%) | 304 (62%) |
Female | 184 (38%) | 190 (38%) |